Description
BLOOD AND BLOOD PRODUCTS
First action · last action
2015-12-31 · 2020-03-30
Transactions
7
First transaction's obligation
$848,796
Base + all options value (sum of deltas)
$1,577,631
Extent competed
NOT AVAILABLE FOR COMPETITION
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA24816D0029
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-12-31+$848,796= $848,796
- Mod P000012017-04-05-$266,556= $582,240
- Mod P000032018-01-01+$892,396= $1,474,636
- Mod P000042019-01-01+$913,303= $2,387,939
- Mod P000022019-04-05-$387,315= $2,000,624
- Mod P000052019-09-12-$312,000= $1,688,624
- Mod P000062020-03-30-$110,993= $1,577,631
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-12-31 | +$848,796 | $848,796 | BLOOD AND BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2017-04-05 | −$266,556 | $582,240 | BLOOD AND BLOOD PRODUCTS |
| Mod P00003· EXERCISE AN OPTION | 2018-01-01 | +$892,396 | $1,474,636 | BLOOD AND BLOOD PRODUCTS |
| Mod P00004· EXERCISE AN OPTION | 2019-01-01 | +$913,303 | $2,387,939 | BLOOD AND BLOOD PRODUCTS |
| Mod P00002· FUNDING ONLY ACTION | 2019-04-05 | −$387,315 | $2,000,624 | BLOOD AND BLOOD PRODUCTS |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2019-09-12 | −$312,000 | $1,688,624 | BLOOD AND BLOOD PRODUCTS |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2020-03-30 | −$110,993 | $1,577,631 | BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6515 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826P1275 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $9,800 | FY2026 |
| 36C24826N0893 | GLOMAX, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $309,731 | FY2026 |
| 36C24826N0898 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $13,348 | FY2026 |
| 36C24826N0895 | PERMOBIL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $18,598 | FY2026 |
| 36C24826N0860 | DISORB SYSTEMS INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,238 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24816J0636_3600_VA24816D0029_3600 · retrieved 2026-09-26.